| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cell adhesion molecule binding | DSP PFKP TENM2 EMILIN1 MRTFB MB21D2 CDH20 PTPRD PTPRF PTPRH EIF2S3 NECTIN2 SLC14A2 CDH6 CDH9 FERMT3 ZC3HAV1 | 7.22e-06 | 599 | 161 | 17 | GO:0050839 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 8.93e-06 | 17 | 161 | 4 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 8.93e-06 | 17 | 161 | 4 | GO:0019198 | |
| GeneOntologyMolecularFunction | glutamine-fructose-6-phosphate transaminase (isomerizing) activity | 6.46e-05 | 2 | 161 | 2 | GO:0004360 | |
| GeneOntologyMolecularFunction | L-glutamine aminotransferase activity | 1.93e-04 | 3 | 161 | 2 | GO:0070548 | |
| GeneOntologyMolecularFunction | hexose-phosphate:phosphate antiporter activity | 3.84e-04 | 4 | 161 | 2 | GO:0015526 | |
| GeneOntologyMolecularFunction | hexose phosphate transmembrane transporter activity | 3.84e-04 | 4 | 161 | 2 | GO:0015119 | |
| GeneOntologyMolecularFunction | glucose-6-phosphate transmembrane transporter activity | 3.84e-04 | 4 | 161 | 2 | GO:0015152 | |
| GeneOntologyMolecularFunction | glucose 6-phosphate:phosphate antiporter activity | 3.84e-04 | 4 | 161 | 2 | GO:0061513 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO1G ERCC6L ATP13A1 GPN1 MCM3 CCT4 MCM7 DNAH14 CCT6A UBA1 ATP6V1H MCM9 CCT6B ATP1A4 | 4.64e-04 | 614 | 161 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 4.82e-04 | 171 | 161 | 7 | GO:0015103 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC37A1 SLC2A9 ATP13A1 SLC26A4 COX15 SLC12A8 SLC1A5 ATP6V1H SLC13A4 SLC22A4 SLC37A2 ATP1A4 | 5.04e-04 | 477 | 161 | 12 | GO:0022804 |
| GeneOntologyMolecularFunction | phosphatase activity | 5.49e-04 | 287 | 161 | 9 | GO:0016791 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 6.55e-04 | 130 | 161 | 6 | GO:0005200 | |
| GeneOntologyMolecularFunction | single-stranded DNA helicase activity | 8.09e-04 | 23 | 161 | 3 | GO:0017116 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 8.72e-04 | 189 | 161 | 7 | GO:0004721 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ERCC6L ATP13A1 GPN1 MCM3 CCT4 MCM7 CCT6A ATP6V1H MCM9 CCT6B ATP1A4 | 9.25e-04 | 441 | 161 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | carboxylesterase activity | 9.49e-04 | 6 | 161 | 2 | GO:0106435 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 1.19e-03 | 386 | 161 | 10 | GO:0042578 | |
| GeneOntologyMolecularFunction | organophosphate:phosphate antiporter activity | 1.32e-03 | 7 | 161 | 2 | GO:0015315 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 1.48e-03 | 103 | 161 | 5 | GO:0004725 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ARL16 ERCC6L ATP13A1 GPN1 MCM3 CCT4 EIF2S3B MCM7 CCT6A ATP6V1H EIF2S3 MCM9 ENTPD5 CCT6B ATP1A4 | 1.54e-03 | 775 | 161 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | cadherin binding | 1.76e-03 | 339 | 161 | 9 | GO:0045296 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DSG1 WNK1 TENM2 CDH20 PTPRD PTPRF PTPRG PTPRS NECTIN2 PCDH7 CDH6 CDH9 | 6.29e-06 | 313 | 160 | 12 | GO:0098742 |
| GeneOntologyBiologicalProcess | synaptic membrane adhesion | 1.78e-05 | 42 | 160 | 5 | GO:0099560 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | DSG1 TNFSF9 DSP VTCN1 IGDCC3 NCAM1 WNK1 TENM2 EMILIN1 FBXO38 CDH20 PTPRD PTPRF PTPRG PTPRS MAD1L1 NECTIN2 PKHD1 PCDH7 CDH6 CDH9 FERMT3 | 3.10e-05 | 1077 | 160 | 22 | GO:0098609 |
| GeneOntologyCellularComponent | MCM complex | 7.07e-05 | 11 | 161 | 3 | GO:0042555 | |
| GeneOntologyCellularComponent | chaperonin-containing T-complex | 7.07e-05 | 11 | 161 | 3 | GO:0005832 | |
| GeneOntologyCellularComponent | postsynaptic membrane | SHANK1 GPHN LRFN1 NCAM1 GRIA4 GRM3 TENM2 PTPRF NETO2 PTPRS CDH9 GABRA3 | 7.39e-05 | 405 | 161 | 12 | GO:0045211 |
| Domain | FN3 | COL6A3 LRFN1 IGDCC3 NCAM1 PTPRD PTPRF PTPRG PTPRH PTPRS MYBPC3 | 4.25e-06 | 185 | 159 | 10 | SM00060 |
| Domain | FN3 | COL6A3 LRFN1 IGDCC3 NCAM1 PTPRD PTPRF PTPRG PTPRH PTPRS MYBPC3 | 8.10e-06 | 199 | 159 | 10 | PS50853 |
| Domain | fn3 | 1.04e-05 | 162 | 159 | 9 | PF00041 | |
| Domain | FN3_dom | COL6A3 LRFN1 IGDCC3 NCAM1 PTPRD PTPRF PTPRG PTPRH PTPRS MYBPC3 | 1.24e-05 | 209 | 159 | 10 | IPR003961 |
| Domain | PTPc | 1.28e-05 | 36 | 159 | 5 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 1.91e-05 | 39 | 159 | 5 | PS50055 | |
| Domain | ApoL | 2.07e-05 | 7 | 159 | 3 | PF05461 | |
| Domain | ApoL | 2.07e-05 | 7 | 159 | 3 | IPR008405 | |
| Domain | PTPase_domain | 2.46e-05 | 41 | 159 | 5 | IPR000242 | |
| Domain | Y_phosphatase | 2.46e-05 | 41 | 159 | 5 | PF00102 | |
| Domain | MCM_OB | 3.29e-05 | 8 | 159 | 3 | PF17207 | |
| Domain | MCM_OB | 3.29e-05 | 8 | 159 | 3 | IPR033762 | |
| Domain | MCM_2 | 3.29e-05 | 8 | 159 | 3 | PS50051 | |
| Domain | MCM_1 | 3.29e-05 | 8 | 159 | 3 | PS00847 | |
| Domain | Ig_I-set | 3.70e-05 | 190 | 159 | 9 | IPR013098 | |
| Domain | I-set | 3.70e-05 | 190 | 159 | 9 | PF07679 | |
| Domain | MCM | 4.90e-05 | 9 | 159 | 3 | SM00350 | |
| Domain | MCM_dom | 4.90e-05 | 9 | 159 | 3 | IPR001208 | |
| Domain | Chaprnin_Cpn60 | 4.90e-05 | 9 | 159 | 3 | IPR001844 | |
| Domain | Chaperonin_TCP-1_CS | 4.90e-05 | 9 | 159 | 3 | IPR002194 | |
| Domain | MCM | 4.90e-05 | 9 | 159 | 3 | IPR031327 | |
| Domain | MCM | 4.90e-05 | 9 | 159 | 3 | PF00493 | |
| Domain | Cadherin_C | 5.56e-05 | 25 | 159 | 4 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 5.56e-05 | 25 | 159 | 4 | IPR000233 | |
| Domain | TCP1_1 | 6.95e-05 | 10 | 159 | 3 | PS00750 | |
| Domain | TCP1_2 | 6.95e-05 | 10 | 159 | 3 | PS00751 | |
| Domain | TCP1_3 | 6.95e-05 | 10 | 159 | 3 | PS00995 | |
| Domain | Chaperone_TCP-1 | 6.95e-05 | 10 | 159 | 3 | IPR017998 | |
| Domain | Chap_CCT_zeta | 7.20e-05 | 2 | 159 | 2 | IPR012722 | |
| Domain | GlmS_trans | 7.20e-05 | 2 | 159 | 2 | IPR005855 | |
| Domain | SIS | 7.20e-05 | 2 | 159 | 2 | PF01380 | |
| Domain | - | 7.20e-05 | 2 | 159 | 2 | 1.10.45.10 | |
| Domain | - | 9.50e-05 | 11 | 159 | 3 | 3.30.260.10 | |
| Domain | TCP-1-like_intermed | 9.50e-05 | 11 | 159 | 3 | IPR027410 | |
| Domain | TYR_PHOSPHATASE_dom | 9.90e-05 | 87 | 159 | 6 | IPR000387 | |
| Domain | Catenin_binding_dom | 1.02e-04 | 29 | 159 | 4 | IPR027397 | |
| Domain | - | 1.02e-04 | 29 | 159 | 4 | 4.10.900.10 | |
| Domain | WWE | 1.26e-04 | 12 | 159 | 3 | PF02825 | |
| Domain | WWE-dom | 1.26e-04 | 12 | 159 | 3 | IPR004170 | |
| Domain | WWE | 1.26e-04 | 12 | 159 | 3 | PS50918 | |
| Domain | IGc2 | 1.88e-04 | 235 | 159 | 9 | SM00408 | |
| Domain | Ig_sub2 | 1.88e-04 | 235 | 159 | 9 | IPR003598 | |
| Domain | GROEL-like_equatorial | 2.06e-04 | 14 | 159 | 3 | IPR027413 | |
| Domain | - | 2.06e-04 | 14 | 159 | 3 | 1.10.560.10 | |
| Domain | Arp3_met | 2.15e-04 | 3 | 159 | 2 | IPR015623 | |
| Domain | SIS | 2.15e-04 | 3 | 159 | 2 | PS51464 | |
| Domain | FAD-linked_oxidase_C | 2.15e-04 | 3 | 159 | 2 | IPR004113 | |
| Domain | SIS | 2.15e-04 | 3 | 159 | 2 | IPR001347 | |
| Domain | FAD-oxidase_C | 2.15e-04 | 3 | 159 | 2 | PF02913 | |
| Domain | FAD-linked_Oxase-like_C | 2.15e-04 | 3 | 159 | 2 | IPR016164 | |
| Domain | Vanillyl_alc_oxidase_C-sub2 | 2.15e-04 | 3 | 159 | 2 | IPR016171 | |
| Domain | GroEL-like_apical_dom | 2.56e-04 | 15 | 159 | 3 | IPR027409 | |
| Domain | Cpn60/TCP-1 | 2.56e-04 | 15 | 159 | 3 | IPR002423 | |
| Domain | Cpn60_TCP1 | 2.56e-04 | 15 | 159 | 3 | PF00118 | |
| Domain | - | 2.56e-04 | 15 | 159 | 3 | 3.50.7.10 | |
| Domain | Tyr_Pase_AS | 3.96e-04 | 73 | 159 | 5 | IPR016130 | |
| Domain | Oxid_FAD_bind_N | 4.27e-04 | 4 | 159 | 2 | IPR006094 | |
| Domain | FAD_binding_4 | 4.27e-04 | 4 | 159 | 2 | PF01565 | |
| Domain | Sugar_P_transporter | 4.27e-04 | 4 | 159 | 2 | IPR000849 | |
| Domain | GATASE_TYPE_2 | 7.08e-04 | 5 | 159 | 2 | PS51278 | |
| Domain | YTH | 7.08e-04 | 5 | 159 | 2 | PF04146 | |
| Domain | - | 7.08e-04 | 5 | 159 | 2 | 3.30.43.10 | |
| Domain | YTH_domain | 7.08e-04 | 5 | 159 | 2 | IPR007275 | |
| Domain | FAD-bd_2_sub1 | 7.08e-04 | 5 | 159 | 2 | IPR016167 | |
| Domain | YTH | 7.08e-04 | 5 | 159 | 2 | PS50882 | |
| Domain | GATase_2_dom | 7.08e-04 | 5 | 159 | 2 | IPR017932 | |
| Domain | TYR_PHOSPHATASE_1 | 8.39e-04 | 86 | 159 | 5 | PS00383 | |
| Domain | TYR_PHOSPHATASE_2 | 8.85e-04 | 87 | 159 | 5 | PS50056 | |
| Domain | IG | HSPG2 LRFN1 VTCN1 IGDCC3 NCAM1 PTPRD PTPRF PTPRS NECTIN2 CEACAM20 MYBPC3 | 9.80e-04 | 421 | 159 | 11 | SM00409 |
| Domain | Ig_sub | HSPG2 LRFN1 VTCN1 IGDCC3 NCAM1 PTPRD PTPRF PTPRS NECTIN2 CEACAM20 MYBPC3 | 9.80e-04 | 421 | 159 | 11 | IPR003599 |
| Domain | Ig-like_fold | HSPG2 COL6A3 LRFN1 VTCN1 IGDCC3 NCAM1 PTPRD PTPRF PTPRG PTPRH PTPRS NECTIN2 PKHD1 CEACAM20 MYBPC3 | 1.04e-03 | 706 | 159 | 15 | IPR013783 |
| Domain | - | 1.06e-03 | 6 | 159 | 2 | 3.30.465.10 | |
| Domain | MCM_N | 1.06e-03 | 6 | 159 | 2 | PF14551 | |
| Domain | MCM_CS | 1.06e-03 | 6 | 159 | 2 | IPR018525 | |
| Domain | MCM_N | 1.06e-03 | 6 | 159 | 2 | IPR027925 | |
| Domain | FAD_PCMH | 1.06e-03 | 6 | 159 | 2 | PS51387 | |
| Domain | CO_DH_flavot_FAD-bd_sub2 | 1.06e-03 | 6 | 159 | 2 | IPR016169 | |
| Domain | FAD-bd_2 | 1.06e-03 | 6 | 159 | 2 | IPR016166 | |
| Domain | - | 1.07e-03 | 24 | 159 | 3 | 3.60.20.10 | |
| Domain | ig | 1.23e-03 | 190 | 159 | 7 | PF00047 | |
| Domain | Immunoglobulin | 1.23e-03 | 190 | 159 | 7 | IPR013151 | |
| Domain | Prot-tyrosine_phosphatase-like | 1.58e-03 | 99 | 159 | 5 | IPR029021 | |
| Domain | PTPc_motif | 1.60e-03 | 59 | 159 | 4 | SM00404 | |
| Domain | Tyr_Pase_cat | 1.60e-03 | 59 | 159 | 4 | IPR003595 | |
| Domain | - | HSPG2 COL6A3 LRFN1 VTCN1 IGDCC3 NCAM1 PTPRD PTPRF PTPRG PTPRS NECTIN2 PKHD1 CEACAM20 MYBPC3 | 1.62e-03 | 663 | 159 | 14 | 2.60.40.10 |
| Domain | PH-BEACH_dom | 1.95e-03 | 8 | 159 | 2 | IPR023362 | |
| Domain | - | 1.95e-03 | 8 | 159 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 1.95e-03 | 8 | 159 | 2 | PS51783 | |
| Domain | Cadherin_CS | 2.41e-03 | 109 | 159 | 5 | IPR020894 | |
| Domain | BEACH | 2.49e-03 | 9 | 159 | 2 | PS50197 | |
| Domain | Beach | 2.49e-03 | 9 | 159 | 2 | PF02138 | |
| Domain | - | 2.49e-03 | 9 | 159 | 2 | 1.10.1540.10 | |
| Domain | Beach | 2.49e-03 | 9 | 159 | 2 | SM01026 | |
| Domain | BEACH_dom | 2.49e-03 | 9 | 159 | 2 | IPR000409 | |
| Domain | Ntn_hydrolases_N | 2.74e-03 | 33 | 159 | 3 | IPR029055 | |
| Domain | CADHERIN_1 | 2.82e-03 | 113 | 159 | 5 | PS00232 | |
| Domain | Cadherin | 2.82e-03 | 113 | 159 | 5 | PF00028 | |
| Domain | CADHERIN_2 | 2.93e-03 | 114 | 159 | 5 | PS50268 | |
| Domain | - | 2.93e-03 | 114 | 159 | 5 | 2.60.40.60 | |
| Domain | CA | 3.04e-03 | 115 | 159 | 5 | SM00112 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 5.07e-07 | 20 | 117 | 5 | MM15485 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 6.61e-07 | 21 | 117 | 5 | M27736 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 7.65e-06 | 87 | 117 | 7 | M27617 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 1.90e-05 | 67 | 117 | 6 | MM15327 | |
| Pathway | REACTOME_FOLDING_OF_ACTIN_BY_CCT_TRIC | 6.41e-05 | 10 | 117 | 3 | M27299 | |
| Pathway | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | 6.41e-05 | 10 | 117 | 3 | MM15004 | |
| Pubmed | SHANK1 GPHN LRFN1 MCC MCM3 NCAM1 GRIA4 CCT4 HUWE1 GRM3 CIT TMEM132B TENM2 NCOR1 UBA1 PTPRD SBF1 AP1B1 PTPRS MAD1L1 MTCL1 WDFY3 PCM1 FERMT3 | 3.11e-11 | 963 | 164 | 24 | 28671696 | |
| Pubmed | CFHR1 HSPG2 COL6A3 ATP13A1 NCAM1 FCGBP PTPRF PTPRG PTPRS ENTPD5 NIPA1 C5 CDH6 | 3.29e-10 | 257 | 164 | 13 | 16335952 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ZXDC HSPG2 LRFN1 LRWD1 ATP13A1 NLRX1 APEH MIB2 HUWE1 MLLT10 WNK1 CIT SLC1A5 TFE3 NCOR1 EHBP1L1 PTPRF SBF1 PTPRS MAD1L1 PCNX1 WDFY3 LTK D2HGDH | 5.00e-10 | 1105 | 164 | 24 | 35748872 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DCAF1 GPHN MCC CCT4 EIF2S3B HUWE1 PFKP SLC1A5 GFPT1 ATP6V1H PTPRD PTPRF SBF1 PTPRH AP1B1 PTPRS SMU1 CCT6B PLS1 PCM1 ZC3HAV1 | 7.59e-09 | 974 | 164 | 21 | 28675297 |
| Pubmed | GPHN ERCC6L DSP MCM3 MCM7 HUWE1 DHRS7B YEATS2 NCOR1 CCT6A UBA1 MRTFB SMU1 KDM6A PCM1 ZC3HAV1 | 8.59e-09 | 549 | 164 | 16 | 38280479 | |
| Pubmed | ARL16 SYNM APEH MCM3 NCAM1 CCT4 MCM7 HUWE1 SLC1A5 TMEM263 NCOR1 CCT6A RIF1 EIF2S3 NECTIN2 PCDH7 PCM1 ZC3HAV1 | 3.30e-08 | 777 | 164 | 18 | 35844135 | |
| Pubmed | APEH MCM7 HUWE1 PFKP WNK1 ACTR3 GFPT1 DHRS7B UBA1 AARS2 AP1B1 EIF2S3 SMU1 ALDH2 ZC3HAV1 | 4.15e-08 | 534 | 164 | 15 | 35032548 | |
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 1.03e-07 | 3 | 164 | 3 | 31985401 | |
| Pubmed | 1.03e-07 | 3 | 164 | 3 | 20139422 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 1.03e-07 | 3 | 164 | 3 | 33656439 | |
| Pubmed | 1.03e-07 | 3 | 164 | 3 | 9784606 | ||
| Pubmed | DSP MAZ CCT4 HUWE1 SLC1A5 ACTR3 PPM1A FBXO38 NCOR1 RIF1 UBA1 PTPRD PTPRF PTPRG SBF1 PTPRH PTPRS NECTIN2 KDM6A PCDH7 | 1.31e-07 | 1049 | 164 | 20 | 27880917 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | LRWD1 ERCC6L DSP MCM3 HUWE1 PFKP FBXO38 YEATS2 NCOR1 RIF1 UBA1 CCNL1 MAD1L1 KDM6A PCDH7 PCM1 ZC3HAV1 | 1.73e-07 | 774 | 164 | 17 | 15302935 |
| Pubmed | HTRA1 DSG1 DSP APEH MCM3 CCT4 EIF2S3B MCM7 PFKP ACTR3 TMEM263 CCT6A UBA1 ATP6V1H EIF2S3 CCT6B ZC3HAV1 | 2.89e-07 | 803 | 164 | 17 | 36517590 | |
| Pubmed | SHANK1 GPHN HTRA1 DSP NCAM1 CCT4 EIF2S3B ACTR3B PFKP GRM3 CIT ACTR3 CCT6A UBA1 ATP6V1H SBF1 AP1B1 PTPRS EIF2S3 SMU1 ALDH2 CROCC PCM1 | 2.92e-07 | 1431 | 164 | 23 | 37142655 | |
| Pubmed | 4.10e-07 | 4 | 164 | 3 | 8524829 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | LRWD1 DSG1 DSP MCM3 CCT4 MCM7 NUP58 HUWE1 PFKP CIT SLC1A5 ACTR3 CCT6A RIF1 UBA1 PTPRF AARS2 SMU1 PCM1 | 4.16e-07 | 1024 | 164 | 19 | 24711643 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | LRWD1 DSG1 DSP COX15 MCM3 CCT4 EIF2S3B MCM7 HUWE1 PFKP SLC1A5 GFPT1 PPM1A DHRS7B NCOR1 CCT6A RIF1 UBA1 ATP6V1H EIF2S3 CCT6B | 5.43e-07 | 1257 | 164 | 21 | 37317656 |
| Pubmed | An integrated workflow for charting the human interaction proteome: insights into the PP2A system. | 7.04e-07 | 105 | 164 | 7 | 19156129 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | LRFN1 TNFSF9 ATP13A1 NLRX1 APOOL CYP2S1 HUWE1 PFKP RIF1 PTPRF NETO2 PTPRS EIF2S3 ALG14 NECTIN2 NIPA1 C5 WDFY3 ALDH2 | 7.07e-07 | 1061 | 164 | 19 | 33845483 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GPHN ERCC6L DSP MAZ PFKP WNK1 SLC1A5 PPM1A VPS13D SBF1 MAD1L1 NECTIN2 MTCL1 PCDH7 PCM1 ZC3HAV1 DYRK2 | 7.56e-07 | 861 | 164 | 17 | 36931259 |
| Pubmed | GPHN MCM3 HUWE1 PFKP WNK1 GFPT1 NCOR1 RIF1 UBA1 MAD1L1 MTCL1 PCM1 ZC3HAV1 | 8.75e-07 | 503 | 164 | 13 | 16964243 | |
| Pubmed | 1.02e-06 | 5 | 164 | 3 | 10777529 | ||
| Pubmed | Complement factor H and related proteins: an expanding family of complement-regulatory proteins? | 1.02e-06 | 5 | 164 | 3 | 8172644 | |
| Pubmed | 1.02e-06 | 5 | 164 | 3 | 22357843 | ||
| Pubmed | Protein tyrosine phosphatases expression during development of mouse superior colliculus. | 1.08e-06 | 17 | 164 | 4 | 19727691 | |
| Pubmed | HSPG2 VEZF1 MAZ CCT4 R3HDM2 MLLT10 PFKP CIT SLC1A5 ACTR3 TFE3 YTHDF1 YEATS2 NCOR1 CCT6A RIF1 GFPT2 KDM6A PCDH7 YTHDF3 PCM1 ZC3HAV1 | 1.11e-06 | 1429 | 164 | 22 | 35140242 | |
| Pubmed | 1.39e-06 | 18 | 164 | 4 | 29507117 | ||
| Pubmed | Sex differences in sex chromosome gene expression in mouse brain. | 1.39e-06 | 18 | 164 | 4 | 12023983 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | DTD1 GPHN GPN1 APEH MCM3 CCT4 MCM7 HUWE1 PFKP WNK1 ACTR3 GFPT1 CCT6A UBA1 EHBP1L1 ATP6V1H AP1B1 EIF2S3 MAD1L1 CROCC PLS1 TRMT61A | 1.49e-06 | 1455 | 164 | 22 | 22863883 |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | ATP13A1 NCAM1 CCT4 EIF2S3B MCM7 HUWE1 PFKP CCT6A AP1B1 EIF2S3 CCT6B ALDH2 ATP1A4 KDM6A | 1.64e-06 | 621 | 164 | 14 | 22794259 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DCAF1 LRWD1 DSG1 DSP MCM3 CCT4 MCM7 HUWE1 PFKP SLC1A5 ACTR3 GFPT1 CCT6A RIF1 UBA1 SBF1 SMU1 CCT6B WDFY3 ALOX12B ZC3HAV1 | 1.75e-06 | 1353 | 164 | 21 | 29467282 |
| Pubmed | 2.04e-06 | 6 | 164 | 3 | 19273906 | ||
| Pubmed | Receptor protein tyrosine phosphatases are novel components of a polycystin complex. | 2.04e-06 | 6 | 164 | 3 | 21126580 | |
| Pubmed | ERCC6L MCM3 CCT4 MCM7 HUWE1 YTHDF1 CCT6A RIF1 UBA1 AARS2 AP1B1 EIF2S3 SMU1 ZC3HAV1 | 2.25e-06 | 638 | 164 | 14 | 33239621 | |
| Pubmed | ERCC6L GFPT1 TFE3 YEATS2 NCOR1 EHBP1L1 AP1B1 APOL6 APOL3 MTCL1 C5 WDFY3 GFPT2 KDM6A | 2.25e-06 | 638 | 164 | 14 | 31182584 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYO1G DSP CCT4 MCM7 HUWE1 ACTR3B PSMA8 ACTR3 GFPT1 UBA1 AARS2 AP1B1 ALOX12B YTHDF3 | 2.64e-06 | 647 | 164 | 14 | 26618866 |
| Pubmed | HSPG2 DSG1 DSP MCM3 CCT4 MCM7 ACTR3B PFKP PSMA8 SLC1A5 ACTR3 GFPT1 YTHDF1 CCT6A CCT6B YTHDF3 | 2.74e-06 | 844 | 164 | 16 | 25963833 | |
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 2.76e-06 | 315 | 164 | 10 | 26777405 | |
| Pubmed | MYO1G DSP APEH CCT4 PFKP SLC1A5 ACTR3 GFPT1 CCT6A UBA1 EIF2S3 FGR FERMT3 | 3.14e-06 | 565 | 164 | 13 | 20458337 | |
| Pubmed | 3.55e-06 | 7 | 164 | 3 | 12376545 | ||
| Pubmed | 3.55e-06 | 7 | 164 | 3 | 29073098 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | GPHN MCM3 CCT4 MCM7 HUWE1 PFKP ACTR3 GFPT1 UBA1 AP1B1 CCT6B GFPT2 PCM1 ZC3HAV1 | 3.62e-06 | 665 | 164 | 14 | 30457570 |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | 3.87e-06 | 256 | 164 | 9 | 35777956 | |
| Pubmed | 4.17e-06 | 330 | 164 | 10 | 32529326 | ||
| Pubmed | HSPG2 VEZF1 DSP MAZ CCT4 MCM7 HUWE1 ACTR3B SLC1A5 ACTR3 CCT6A UBA1 ATP6V1H AARS2 AP1B1 ALDH2 | 4.52e-06 | 878 | 164 | 16 | 37223481 | |
| Pubmed | 4.54e-06 | 196 | 164 | 8 | 19334288 | ||
| Pubmed | GPHN LRWD1 CCT4 ACTR3 YEATS2 CCT6A RIF1 UBA1 MRTFB SMU1 CCT6B PLS1 | 5.61e-06 | 506 | 164 | 12 | 30890647 | |
| Pubmed | 5.67e-06 | 8 | 164 | 3 | 37591863 | ||
| Pubmed | 5.67e-06 | 8 | 164 | 3 | 28637841 | ||
| Pubmed | NLRX1 GPN1 COX15 HUWE1 PFKP ACTR3 TMEM263 DHRS7B RIF1 VPS13D ATP6V1H AARS2 ZC3HAV1 | 6.68e-06 | 606 | 164 | 13 | 36538041 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | DSP MUC19 MCM3 CCT4 MCM7 HUWE1 PFKP SLC1A5 ACTR3 GFPT1 CCT6A SLC13A4 AP1B1 EIF2S3 PCNX1 | 7.20e-06 | 807 | 164 | 15 | 30575818 |
| Pubmed | ERCC6L DSP MCM3 CCT4 SLC1A5 GFPT1 CCT6A UBA1 ATP6V1H MB21D2 EIF2S3 NECTIN2 PCDH7 ZC3HAV1 | 7.37e-06 | 708 | 164 | 14 | 39231216 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | DSG1 DSP GPN1 APEH CCT4 MCM7 HUWE1 PFKP WNK1 ACTR3 GFPT1 CCT6A UBA1 ATP6V1H MRTFB FCGBP AARS2 AP1B1 NECTIN2 ZC3HAV1 | 7.56e-06 | 1367 | 164 | 20 | 32687490 |
| Pubmed | Phrenic-specific transcriptional programs shape respiratory motor output. | 7.69e-06 | 27 | 164 | 4 | 31944180 | |
| Pubmed | DTD1 FYTTD1 VEZF1 DSG1 DSP ATP13A1 MAZ PSMA8 SLC1A5 ACTR3 GFPT1 TMEM263 YTHDF1 RIF1 AP1B1 SMU1 C5 YTHDF3 PCM1 TRMT61A | 7.89e-06 | 1371 | 164 | 20 | 36244648 | |
| Pubmed | 8.08e-06 | 212 | 164 | 8 | 19521566 | ||
| Pubmed | 8.47e-06 | 9 | 164 | 3 | 9736774 | ||
| Pubmed | 8.47e-06 | 9 | 164 | 3 | 7828721 | ||
| Pubmed | 8.47e-06 | 9 | 164 | 3 | 10336634 | ||
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | FYTTD1 DSG1 GPN1 MCM3 CCT4 HUWE1 PSMA8 YEATS2 NCOR1 ATP6V1H MRTFB EIF2S3 MAD1L1 | 9.12e-06 | 624 | 164 | 13 | 33729478 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GPHN DSG1 ERCC6L DSP CCT4 PFKP WNK1 SLC1A5 GFPT1 YEATS2 RIF1 UBA1 MRTFB EIF2S3 PCM1 ZC3HAV1 | 9.77e-06 | 934 | 164 | 16 | 33916271 |
| Pubmed | 1.07e-05 | 451 | 164 | 11 | 36168627 | ||
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 1.09e-05 | 221 | 164 | 8 | 29991511 | |
| Pubmed | SLC37A1 MYO1G ERCC6L ATP13A1 MCM3 NCAM1 MCM7 HUWE1 PFKP CIT SLC1A5 ACTR3 DHRS7B NCOR1 EHBP1L1 APOL3 PCM1 FERMT3 | 1.12e-05 | 1168 | 164 | 18 | 19946888 | |
| Pubmed | 1.21e-05 | 10 | 164 | 3 | 7953530 | ||
| Pubmed | 1.22e-05 | 107 | 164 | 6 | 30995489 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | DSG1 DSP GPN1 MCM3 CCT4 EIF2S3B MCM7 HUWE1 PFKP WNK1 GFPT1 CCT6A RIF1 UBA1 AP1B1 EIF2S3 SMU1 MTCL1 YTHDF3 ZC3HAV1 | 1.25e-05 | 1415 | 164 | 20 | 28515276 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | DSP MCC MCM3 CCT4 MCM7 PFKP WNK1 CIT ACTR3 YTHDF1 CCT6A SLC13A4 AP1B1 EIF2S3 YTHDF3 | 1.27e-05 | 847 | 164 | 15 | 35235311 |
| Pubmed | LRWD1 DSP MAZ APEH CCT4 PFKP WNK1 SLC1A5 GFPT1 NCOR1 CCT6A UBA1 ATP6V1H EIF2S3 MTCL1 CROCC YTHDF3 PCM1 ZC3HAV1 | 1.28e-05 | 1297 | 164 | 19 | 33545068 | |
| Pubmed | 1.34e-05 | 64 | 164 | 5 | 26511642 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | SHANK1 COX15 MIB2 WNK1 TENM2 YTHDF1 AP1B1 YTHDF3 PCM1 TRMT61A DYRK2 | 1.34e-05 | 462 | 164 | 11 | 31138677 |
| Pubmed | 1.65e-05 | 11 | 164 | 3 | 25624497 | ||
| Pubmed | 1.65e-05 | 11 | 164 | 3 | 7832766 | ||
| Pubmed | 1.65e-05 | 11 | 164 | 3 | 30100344 | ||
| Pubmed | DCAF1 GPN1 MCM3 CCT4 EIF2S3B MCM7 HUWE1 ACTR3B PSMA8 SLC1A5 DHRS7B CCT6A UBA1 AP1B1 SMU1 CCT6B PCNX1 PLS1 ZC3HAV1 | 1.90e-05 | 1335 | 164 | 19 | 29229926 | |
| Pubmed | 1.93e-05 | 173 | 164 | 7 | 23979707 | ||
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 2.08e-05 | 316 | 164 | 9 | 31665637 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | COX15 MCM3 MCM7 HUWE1 PFKP DHRS7B AP1B1 EIF2S3 RNF146 TRMT61A ZC3HAV1 | 2.14e-05 | 486 | 164 | 11 | 30940648 |
| Pubmed | Sexual differentiation in the developing mouse brain: contributions of sex chromosome genes. | 2.20e-05 | 12 | 164 | 3 | 23210685 | |
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 2.20e-05 | 12 | 164 | 3 | 9624153 | |
| Pubmed | 2.20e-05 | 12 | 164 | 3 | 22102170 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 33654309 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 32636836 | ||
| Pubmed | Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas. | 2.21e-05 | 2 | 164 | 2 | 26504025 | |
| Pubmed | Deletion of YTHDF1 (not YTHDF3) reduced brain and gut damage after traumatic brain injury. | 2.21e-05 | 2 | 164 | 2 | 39081030 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 11112347 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 24324072 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 7665159 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 28106076 | ||
| Pubmed | Molecular cloning of a human serum protein structurally related to complement factor H. | 2.21e-05 | 2 | 164 | 2 | 1711047 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 10806390 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 19528535 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 9060444 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 33651882 | ||
| Pubmed | Cardiomyocyte protein O-GlcNAcylation is regulated by GFAT1 not GFAT2. | 2.21e-05 | 2 | 164 | 2 | 34735873 | |
| Pubmed | Cloning of cell-specific secreted and surface proteins by subtractive antibody screening. | 2.21e-05 | 2 | 164 | 2 | 9624692 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 9566880 | ||
| Pubmed | Sexually dimorphic expression of the X-linked gene Eif2s3x mRNA but not protein in mouse brain. | 2.21e-05 | 2 | 164 | 2 | 16325480 | |
| Pubmed | 2.23e-05 | 35 | 164 | 4 | 23716698 | ||
| Interaction | PLAC8L1 interactions | 3.15e-07 | 19 | 160 | 5 | int:PLAC8L1 | |
| Interaction | TOP3B interactions | ZXDC HSPG2 LRFN1 LRWD1 ATP13A1 NLRX1 APEH R3HDM2 MIB2 HUWE1 MLLT10 PFKP WNK1 CIT SLC1A5 ACTR3 TFE3 YTHDF1 NCOR1 EHBP1L1 PTPRF SBF1 PTPRS MAD1L1 PCNX1 WDFY3 LTK D2HGDH YTHDF3 ZC3HAV1 | 1.48e-06 | 1470 | 160 | 30 | int:TOP3B |
| Interaction | SECISBP2 interactions | 2.87e-06 | 78 | 160 | 7 | int:SECISBP2 | |
| Interaction | CCT4 interactions | ARL16 GPN1 CCT4 MCM7 HUWE1 ACTR3B CIT ACTR3 TFE3 CCT6A STRADB PLAC8L1 SMU1 CCT6B FGR PCDH7 | 3.61e-06 | 515 | 160 | 16 | int:CCT4 |
| Interaction | TMEM30B interactions | 5.12e-06 | 85 | 160 | 7 | int:TMEM30B | |
| Interaction | TRMT61A interactions | 8.67e-06 | 92 | 160 | 7 | int:TRMT61A | |
| Interaction | CCT6A interactions | GPN1 CCT4 HUWE1 ACTR3B CIT WDFY4 ACTR3 GFPT1 TFE3 CCT6A STRADB PLAC8L1 CCT6B FGR PCDH7 TRMT61A | 1.29e-05 | 570 | 160 | 16 | int:CCT6A |
| Interaction | SEC31B interactions | 3.01e-05 | 23 | 160 | 4 | int:SEC31B | |
| Interaction | CCT8 interactions | ARL16 GPN1 CCT4 HUWE1 ACTR3B CIT ACTR3 GFPT1 TFE3 CCT6A STRADB CCT6B GFPT2 FGR PCDH7 | 3.39e-05 | 550 | 160 | 15 | int:CCT8 |
| Interaction | PCDHGB1 interactions | 3.39e-05 | 77 | 160 | 6 | int:PCDHGB1 | |
| Interaction | WDR5B interactions | 4.70e-05 | 50 | 160 | 5 | int:WDR5B | |
| Interaction | TIGIT interactions | 4.99e-05 | 26 | 160 | 4 | int:TIGIT | |
| Interaction | INPP4B interactions | 5.82e-05 | 27 | 160 | 4 | int:INPP4B | |
| Interaction | LDHB interactions | COL6A3 ARL16 HUWE1 GFPT1 TFE3 CCT6A UBA1 PTPRF CCT6B ALDH2 PCDH7 | 6.29e-05 | 327 | 160 | 11 | int:LDHB |
| Interaction | MGARP interactions | 7.26e-05 | 222 | 160 | 9 | int:MGARP | |
| Interaction | FOLH1B interactions | 7.73e-05 | 11 | 160 | 3 | int:FOLH1B | |
| Interaction | STRADB interactions | 7.78e-05 | 29 | 160 | 4 | int:STRADB | |
| Interaction | CCT3 interactions | CCT4 MCM7 MIB2 HUWE1 ACTR3B CIT WDFY4 ACTR3 TFE3 CCT6A STRADB PLAC8L1 CCT6B FGR PCDH7 | 9.72e-05 | 604 | 160 | 15 | int:CCT3 |
| Interaction | MAPK6 interactions | DSP GPN1 MCM3 CCT4 MCM7 HUWE1 WDFY4 SLC1A5 CCT6A RIF1 ATP6V1H EIF2S3 NECTIN2 | 1.09e-04 | 474 | 160 | 13 | int:MAPK6 |
| Interaction | FFAR1 interactions | SLC12A8 CYP2S1 TMEM263 DHRS7B ATP6V1H PTPRD PTPRF WDFY3 GFPT2 | 1.12e-04 | 235 | 160 | 9 | int:FFAR1 |
| Interaction | TTLL9 interactions | 1.32e-04 | 13 | 160 | 3 | int:TTLL9 | |
| Interaction | OMG interactions | 1.32e-04 | 13 | 160 | 3 | int:OMG | |
| Interaction | TNFSF8 interactions | 1.35e-04 | 141 | 160 | 7 | int:TNFSF8 | |
| Interaction | TCP1 interactions | GPN1 CCT4 HUWE1 ACTR3B CIT WDFY4 ACTR3 TFE3 CCT6A STRADB PLAC8L1 CCT6B FGR PCDH7 | 1.59e-04 | 561 | 160 | 14 | int:TCP1 |
| Interaction | EEF1AKMT3 interactions | ERCC6L CCT4 HUWE1 WNK1 YTHDF1 CCT6A UBA1 EHBP1L1 SBF1 CCT6B MTCL1 | 1.62e-04 | 364 | 160 | 11 | int:EEF1AKMT3 |
| Interaction | LFNG interactions | 1.68e-04 | 14 | 160 | 3 | int:LFNG | |
| Interaction | CLEC4A interactions | 1.73e-04 | 103 | 160 | 6 | int:CLEC4A | |
| Interaction | CD274 interactions | DCAF1 DSG1 DSP MCM7 MIB2 HUWE1 CIT DHRS7B CCT6A EIF2S3 ALOX12B | 1.82e-04 | 369 | 160 | 11 | int:CD274 |
| Interaction | ACE2 interactions | SHANK1 HSPG2 DSG1 DSP CCT4 MCM7 PFKP CIT SLC1A5 ACTR3 YTHDF1 CCT6A MB21D2 PTPRD PTPRF AP1B1 EIF2S3 SMU1 PLS1 YTHDF3 ZC3HAV1 | 1.84e-04 | 1106 | 160 | 21 | int:ACE2 |
| Interaction | CFHR2 interactions | 1.87e-04 | 3 | 160 | 2 | int:CFHR2 | |
| Interaction | CYLD interactions | DSG1 DSP MUC19 CCT4 MCM7 MIB2 HUWE1 CIT PPM1A YEATS2 CCT6A MRTFB EIF2S3 MTCL1 ATP1A4 ALOX12B PCM1 ZC3HAV1 | 1.90e-04 | 868 | 160 | 18 | int:CYLD |
| Interaction | TUBG2 interactions | 2.06e-04 | 37 | 160 | 4 | int:TUBG2 | |
| Interaction | ATXN1 interactions | GPHN ZXDC MCM3 NCAM1 CCT4 MCM7 SLC12A8 R3HDM2 HUWE1 PFKP WNK1 ACTR3 GFPT1 NCOR1 UBA1 AP1B1 CCT6B GFPT2 PCM1 ZC3HAV1 | 2.21e-04 | 1039 | 160 | 20 | int:ATXN1 |
| Interaction | FBXO42 interactions | 2.32e-04 | 259 | 160 | 9 | int:FBXO42 | |
| Interaction | AIMP2 interactions | DSG1 DSP MCM3 CCT4 MCM7 INPP4B CCT6A UBA1 AP1B1 NETO2 KRT36 ZC3HAV1 | 2.40e-04 | 446 | 160 | 12 | int:AIMP2 |
| Interaction | KDM4B interactions | 2.53e-04 | 71 | 160 | 5 | int:KDM4B | |
| Interaction | DLG4 interactions | SHANK1 LRFN1 NCAM1 GRIA4 HUWE1 GRM3 CIT TENM2 UBA1 PTPRG NETO2 GABRA3 | 2.55e-04 | 449 | 160 | 12 | int:DLG4 |
| Interaction | ACTRT1 interactions | 2.55e-04 | 16 | 160 | 3 | int:ACTRT1 | |
| Interaction | TTLL3 interactions | 2.55e-04 | 16 | 160 | 3 | int:TTLL3 | |
| Interaction | FAM86B2 interactions | 2.55e-04 | 16 | 160 | 3 | int:FAM86B2 | |
| Interaction | OPTC interactions | 2.55e-04 | 16 | 160 | 3 | int:OPTC | |
| Interaction | NDN interactions | DSP EID2B MCM3 CCT4 MCM7 HUWE1 CCT6A UBA1 MRTFB EIF2S3 PCM1 ZC3HAV1 | 2.76e-04 | 453 | 160 | 12 | int:NDN |
| Interaction | TBL1Y interactions | 2.80e-04 | 40 | 160 | 4 | int:TBL1Y | |
| Interaction | PGAM4 interactions | 2.80e-04 | 40 | 160 | 4 | int:PGAM4 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 1.31e-07 | 21 | 108 | 5 | 813 | |
| GeneFamily | Fibronectin type III domain containing | 4.92e-07 | 160 | 108 | 9 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.18e-07 | 161 | 108 | 9 | 593 | |
| GeneFamily | MCM family | 1.70e-05 | 9 | 108 | 3 | 1085 | |
| GeneFamily | CD molecules|Type II classical cadherins | 5.68e-05 | 13 | 108 | 3 | 1186 | |
| GeneFamily | Chaperonins | 8.95e-05 | 15 | 108 | 3 | 587 | |
| GeneFamily | Solute carriers | SLC37A1 SLC2A9 SLC26A4 SLC12A8 SLC1A5 SLC13A4 SLC22A4 SLC37A2 SLC14A2 | 6.03e-04 | 395 | 108 | 9 | 752 |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.24e-03 | 9 | 108 | 2 | 1230 | |
| GeneFamily | Complement system|Sushi domain containing | 1.28e-03 | 36 | 108 | 3 | 492 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 3.51e-03 | 51 | 108 | 3 | 870 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.84e-07 | 193 | 163 | 8 | bbdfda6665941cfa1965418bb91ef9ff43b1326f | |
| ToppCell | Club_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 2.80e-06 | 167 | 163 | 7 | dbdaaeb3bd9139cb008d9fe24ec031fc5628f136 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.68e-06 | 174 | 163 | 7 | 9f2e253694eb5860c00528fda31c305c6de8a2a1 | |
| ToppCell | LPS_only-Unknown-Endothelial-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.19e-06 | 115 | 163 | 6 | c67145d3cd9243994a141749b426ff2a6dcc8d93 | |
| ToppCell | LPS_only-Unknown-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.19e-06 | 115 | 163 | 6 | ad5298c2ad8bf94fa13c2e50b0799e929473ef59 | |
| ToppCell | LPS_only-Unknown|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.19e-06 | 115 | 163 | 6 | 7a733f6987b40ec497a03734b79ed5355ad3a2fc | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-06 | 183 | 163 | 7 | a253ad65673fce6cb453e709cb235ce7cbfa18b7 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-06 | 183 | 163 | 7 | ddc45fb591ba0ce3fa05c08051d58286a89ef835 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-06 | 186 | 163 | 7 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-06 | 188 | 163 | 7 | 61f010c165826b434ca3d27553d4c9e13d2c0c51 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-06 | 188 | 163 | 7 | 7553ef7de3575af4cf34704b405b551c1af8eb83 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.33e-06 | 189 | 163 | 7 | 0abc7a4900cc9033bc1be69b770ccc54a6bf41b4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-06 | 190 | 163 | 7 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 7.02e-06 | 192 | 163 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-06 | 192 | 163 | 7 | ec1fd2fb6e71f87189d66261909a84e2be63cacb | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.02e-06 | 192 | 163 | 7 | 7ae3e1ca8bfc078c0e12a1595ecb0e343dab5d2f | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 7.26e-06 | 193 | 163 | 7 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.51e-06 | 194 | 163 | 7 | 48063c9fe3e12aeff0707acada1baa2f8621f093 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.51e-06 | 194 | 163 | 7 | 4f31d2cf7eb37b45fefc4da5b41aac0bfdd847b3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.51e-06 | 194 | 163 | 7 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.51e-06 | 194 | 163 | 7 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.76e-06 | 195 | 163 | 7 | c5f33b420c9ac14dc67fea632b8c2bc2442cbf3d | |
| ToppCell | 11.5-Distal-Mesenchymal-Airway_Smooth_Muscle|Distal / Age, Tissue, Lineage and Cell class | 8.03e-06 | 196 | 163 | 7 | 05530fe7a5681c2f39b95016cd22ef99d6ac0430 | |
| ToppCell | facs-Trachea|facs / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.03e-06 | 196 | 163 | 7 | 8209f2b0f7efebaaf81d642d18a1aee8a9a8dcf6 | |
| ToppCell | facs-Trachea|facs / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.03e-06 | 196 | 163 | 7 | 34020d6553309daa269dff05de0a8567211ea4d2 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-myocytic|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.03e-06 | 196 | 163 | 7 | 20dc9b25ecc23b6e6e52bbab8b5a404f3245ca37 | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.30e-06 | 197 | 163 | 7 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.30e-06 | 197 | 163 | 7 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.30e-06 | 197 | 163 | 7 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega|Control_saline / Treatment groups by lineage, cell group, cell type | 8.57e-06 | 198 | 163 | 7 | 1a39a98beef68e1e6d3adc25270a3336fcc5baf4 | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|Control_saline / Treatment groups by lineage, cell group, cell type | 8.57e-06 | 198 | 163 | 7 | dd80fd9671ee863aebcf4c1023d3e004cc2ee709 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 8.57e-06 | 198 | 163 | 7 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.57e-06 | 198 | 163 | 7 | 43a2ce64fa309bac89a44ea320e87ae2cc39f782 | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary|Control_saline / Treatment groups by lineage, cell group, cell type | 8.57e-06 | 198 | 163 | 7 | cfc2a860bae883299987d3e374d0476ca20e1bdd | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE-O1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 8.81e-06 | 76 | 163 | 5 | 254d18bece2676faa4bbeb8d48b1d327ab3c2215 | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE-O1-Trf|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 8.81e-06 | 76 | 163 | 5 | efbbbf91bca35720d8ecddb076f2c9f4de25e44d | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.15e-06 | 200 | 163 | 7 | c46e06b4f22d3456e67bc62a9ac198e8041965ad | |
| ToppCell | critical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.15e-06 | 200 | 163 | 7 | f39db4250ce220a3eb58edee3f7fc3671701d46f | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 9.15e-06 | 200 | 163 | 7 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.15e-06 | 200 | 163 | 7 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Smooth_muscle-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 9.15e-06 | 200 | 163 | 7 | 78e9a40153d7ba5d9ea6393a37d26fc5c0220867 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.15e-06 | 200 | 163 | 7 | 43b76e382b38b9856c07557a75e5b1ce0cee1d9e | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.96e-05 | 162 | 163 | 6 | 2259e9536147e9cdee772e3a30ba7d104573262c | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-05 | 166 | 163 | 6 | 9adceb746e67e955fd8b3e0984f4eed44b64a270 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.39e-05 | 166 | 163 | 6 | 89e2b8453180983533faccb4275867861876d7ee | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 3.87e-05 | 170 | 163 | 6 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.13e-05 | 172 | 163 | 6 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-05 | 176 | 163 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-2|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 4.70e-05 | 176 | 163 | 6 | 179b1778e8f6c4cd777cec971960211e7ba5d84a | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.85e-05 | 177 | 163 | 6 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-05 | 178 | 163 | 6 | d348a9550db940d204706529759dc51e30506b5f | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-05 | 178 | 163 | 6 | 27497dbfcf9bb4dd0bf7caa0bd78c7e85f5c18ee | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.16e-05 | 179 | 163 | 6 | 9dea57494d59abd6e8abf34e31faf53462ea0fa0 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.33e-05 | 180 | 163 | 6 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 5.33e-05 | 180 | 163 | 6 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.49e-05 | 181 | 163 | 6 | 330d4322f4c4373f706273c1f4e218b59051b7fd | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.49e-05 | 181 | 163 | 6 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.49e-05 | 181 | 163 | 6 | 9de2f2cc5f02e0ca599c9e0d2cb1e1e4b5aac112 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.49e-05 | 181 | 163 | 6 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.49e-05 | 181 | 163 | 6 | 3f4d5d79c1286614514b0e8134079d6128a2a23e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 183 | 163 | 6 | 25c96df8ea0c7bbedbb7699ee84ad6234d19cba8 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 183 | 163 | 6 | eb1f1dd12d1e4f1a7029b5396baada23f7c971ff | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 6.02e-05 | 184 | 163 | 6 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-05 | 184 | 163 | 6 | fe4d3def3da4ffdea5ae6bb059f5397efd58fef3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-05 | 185 | 163 | 6 | dbbd348714cd16a4948a04648e914b1e71e2a8ef | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-05 | 185 | 163 | 6 | bea69058afa5aa927fe15c1f8d46460562ec4dd4 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.20e-05 | 185 | 163 | 6 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 6.20e-05 | 185 | 163 | 6 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.39e-05 | 186 | 163 | 6 | 7c1807fca590cdccf7f5734460bac228d33964ca | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.39e-05 | 186 | 163 | 6 | b1edc341d6684b347dc9e21b34f62f51d095d735 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.39e-05 | 186 | 163 | 6 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.39e-05 | 186 | 163 | 6 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.39e-05 | 186 | 163 | 6 | 10565fce7e1b4ec88bc8e1ed6410a83800be5014 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.58e-05 | 187 | 163 | 6 | 218c9b4f28499389c43005d9626af2ac01066027 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.58e-05 | 187 | 163 | 6 | 9c1013720c248ef201d010806b6e7ad24205e8ee | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.58e-05 | 187 | 163 | 6 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.58e-05 | 187 | 163 | 6 | c7ac4b328efc2ebb72f71154661914193ff402ca | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.58e-05 | 187 | 163 | 6 | 387cb27c8a20031cd87381a9e1172f1f62e1488b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.58e-05 | 187 | 163 | 6 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2-Excitatory_Neuron.Slc17a7.Calb2-Vgll3_(Dentate_hilum?)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.91e-05 | 60 | 163 | 4 | aa75fef294803ec6396c7d2c1f51d52bc4a5b43f | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2-Excitatory_Neuron.Slc17a7.Calb2-Vgll3_(Dentate_hilum?)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.91e-05 | 60 | 163 | 4 | 069fbabfd0e48e5809ff01a026439fd0bd017779 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 189 | 163 | 6 | 039b1922c85aa749d6578583d9d41a4eef8a6ac4 | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.98e-05 | 189 | 163 | 6 | 46c5b975fb9d33017f2d9b7770d45a8bdf95baa2 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.18e-05 | 190 | 163 | 6 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-05 | 190 | 163 | 6 | c7bd087f36321cec61b98657433b4d19d135791f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-05 | 190 | 163 | 6 | 834218fcc59df5e7e52de154272f3d55d81d0dac | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.39e-05 | 191 | 163 | 6 | 04faa7d2237e45418611153294eb6f7bb690cbde | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.39e-05 | 191 | 163 | 6 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-05 | 191 | 163 | 6 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.39e-05 | 191 | 163 | 6 | 79e7089022063c5f2b2f1b27658c62b741f3a037 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.39e-05 | 191 | 163 | 6 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.39e-05 | 191 | 163 | 6 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.39e-05 | 191 | 163 | 6 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 7.39e-05 | 191 | 163 | 6 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.39e-05 | 191 | 163 | 6 | 997abf0cc5873bed0372c4a333ed307fa72774d2 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-05 | 192 | 163 | 6 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.61e-05 | 192 | 163 | 6 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-05 | 192 | 163 | 6 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.61e-05 | 192 | 163 | 6 | 859a32c9e4ed6961897b2ccaecde73a599471df9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.61e-05 | 192 | 163 | 6 | 89e1da82fa2069dac7adb9cba3e8b6c0179e0dc5 | |
| Drug | GAMs | 6.70e-06 | 38 | 160 | 5 | CID000002935 | |
| Drug | Ampyrone [83-07-8]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 1.06e-05 | 196 | 160 | 9 | 6845_UP | |
| Drug | sodium | SLC2A9 SLC26A4 GRIA4 CCT4 SLC12A8 HUWE1 WNK1 CIT SLC1A5 GFPT1 PPM1A ATP6V1H SLC13A4 PTPRG SLC22A4 GFPT2 ALDH2 ATP1A4 SLC14A2 GABRA3 | 1.09e-05 | 944 | 160 | 20 | CID000000923 |
| Drug | Trimethoprim [738-70-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.11e-05 | 197 | 160 | 9 | 2307_DN | |
| Drug | Buspirone hydrochloride [33386-08-2]; Up 200; 9.4uM; HL60; HT_HG-U133A | 1.11e-05 | 197 | 160 | 9 | 1282_UP | |
| Drug | Roxarsone [121-19-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 1.15e-05 | 198 | 160 | 9 | 3511_DN | |
| Drug | AC1L1B62 | 1.28e-05 | 21 | 160 | 4 | CID000001299 | |
| Disease | diet measurement | DTD1 NUP210L NCAM1 ACTR3B MLLT10 CIT SYT10 TENM2 DNAH14 INPP4B CDH20 PTPRF MAD1L1 NECTIN2 PKHD1 ALDH2 PCDH7 FERMT3 | 1.83e-05 | 1049 | 161 | 18 | EFO_0008111 |
| Disease | mean arterial pressure | CFHR2 NCAM1 TFE3 YEATS2 TTBK1 PTPRD APOLD1 PKHD1 ALDH2 FGR PLCE1 TRMT61A | 2.05e-05 | 499 | 161 | 12 | EFO_0006340 |
| Disease | MEHMO syndrome (implicated_via_orthology) | 2.96e-05 | 2 | 161 | 2 | DOID:0060801 (implicated_via_orthology) | |
| Disease | Severe dermatitis, multiple allergies, metabolic wasting syndrome | 2.96e-05 | 2 | 161 | 2 | C3809719 | |
| Disease | Striate palmoplantar keratoderma | 8.84e-05 | 3 | 161 | 2 | C4707237 | |
| Disease | attention deficit hyperactivity disorder, mental or behavioural disorder | 8.84e-05 | 3 | 161 | 2 | EFO_0000677, EFO_0003888 | |
| Disease | stroke | 1.44e-04 | 144 | 161 | 6 | EFO_0000712 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.67e-04 | 148 | 161 | 6 | C0279702 | |
| Disease | Machado-Joseph disease (implicated_via_orthology) | 1.76e-04 | 4 | 161 | 2 | DOID:1440 (implicated_via_orthology) | |
| Disease | Chediak-Higashi syndrome (implicated_via_orthology) | 1.76e-04 | 4 | 161 | 2 | DOID:2935 (implicated_via_orthology) | |
| Disease | intrinsic cardiomyopathy (implicated_via_orthology) | 1.97e-04 | 21 | 161 | 3 | DOID:0060036 (implicated_via_orthology) | |
| Disease | disease of metabolism (implicated_via_orthology) | 1.97e-04 | 21 | 161 | 3 | DOID:0014667 (implicated_via_orthology) | |
| Disease | risky sexual behaviour measurement | 3.42e-04 | 169 | 161 | 6 | EFO_0007877 | |
| Disease | azoospermia (implicated_via_orthology) | 4.24e-04 | 27 | 161 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | serum albumin measurement | CFHR1 MCC R3HDM2 MLLT10 EHBP1L1 RNF146 MAD1L1 SLC14A2 PCDH7 XKR5 MYBPC3 | 4.29e-04 | 592 | 161 | 11 | EFO_0004535 |
| Disease | hypopituitarism (implicated_via_orthology) | 4.37e-04 | 6 | 161 | 2 | DOID:9406 (implicated_via_orthology) | |
| Disease | hypertension (is_implicated_in) | 5.43e-04 | 121 | 161 | 5 | DOID:10763 (is_implicated_in) | |
| Disease | Age related macular degeneration | 5.81e-04 | 30 | 161 | 3 | C0242383 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 7.01e-04 | 128 | 161 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 7.01e-04 | 128 | 161 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 7.01e-04 | 128 | 161 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 7.01e-04 | 128 | 161 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 7.01e-04 | 128 | 161 | 5 | C0007134 | |
| Disease | microcephaly (implicated_via_orthology) | 7.04e-04 | 32 | 161 | 3 | DOID:10907 (implicated_via_orthology) | |
| Disease | Complement deficiency disease | 7.71e-04 | 33 | 161 | 3 | C0272242 | |
| Disease | Sudden Cardiac Arrest | 8.11e-04 | 8 | 161 | 2 | C1720824 | |
| Disease | Sudden Cardiac Death | 8.11e-04 | 8 | 161 | 2 | C0085298 | |
| Disease | energy intake | 8.61e-04 | 134 | 161 | 5 | EFO_0003939 | |
| Disease | unipolar depression | GPHN SGPP2 MCC NCAM1 ACTR3B METTL21EP TENM2 LDHD PTPRD PTPRG MCM9 MAD1L1 PKHD1 MTCL1 CDH9 TRMT61A | 9.58e-04 | 1206 | 161 | 16 | EFO_0003761 |
| Disease | C3 glomerulopathy | 1.04e-03 | 9 | 161 | 2 | C4087273 | |
| Disease | leukodystrophy (implicated_via_orthology) | 1.04e-03 | 9 | 161 | 2 | DOID:10579 (implicated_via_orthology) | |
| Disease | personality trait | 1.26e-03 | 39 | 161 | 3 | EFO_0004365 | |
| Disease | aspartate aminotransferase measurement | DTD1 MUC19 R3HDM2 MLLT10 INPP4B CDH20 PTPRD AP1B1 ENTPD5 APOL3 ALDH2 PLCE1 MYBPC3 | 1.43e-03 | 904 | 161 | 13 | EFO_0004736 |
| Disease | kidney disease (implicated_via_orthology) | 1.46e-03 | 41 | 161 | 3 | DOID:557 (implicated_via_orthology) | |
| Disease | complement factor H measurement | 1.46e-03 | 41 | 161 | 3 | EFO_0008097 | |
| Disease | epilepsy | 1.46e-03 | 41 | 161 | 3 | EFO_0000474 | |
| Disease | epilepsy (implicated_via_orthology) | 2.05e-03 | 163 | 161 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | complement factor H-related protein 4 measurement | 2.44e-03 | 49 | 161 | 3 | EFO_0600091 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 2.51e-03 | 335 | 161 | 7 | EFO_0009931 | |
| Disease | receptive language perception, parental genotype effect measurement | 2.58e-03 | 14 | 161 | 2 | EFO_0005686, EFO_0005939 | |
| Disease | Impaired cognition | 2.58e-03 | 14 | 161 | 2 | C0338656 | |
| Disease | Alzheimer disease, visuospatial impairment | 2.58e-03 | 14 | 161 | 2 | EFO_0009752, MONDO_0004975 | |
| Disease | Left ventricular noncompaction | 2.58e-03 | 14 | 161 | 2 | C1960469 | |
| Disease | Testicular Germ Cell Tumor | 2.58e-03 | 14 | 161 | 2 | C1336708 | |
| Disease | smoking behavior | 2.77e-03 | 341 | 161 | 7 | EFO_0004318 | |
| Disease | inherited metabolic disorder (is_implicated_in) | 2.97e-03 | 15 | 161 | 2 | DOID:655 (is_implicated_in) | |
| Disease | waist-hip ratio | PLIN4 MCC NCAM1 TSC22D2 MLLT10 WNK1 YEATS2 PTPRD PTPRG APOLD1 PTPRS RNF146 PCNX1 SLC14A2 PLCE1 | 3.00e-03 | 1226 | 161 | 15 | EFO_0004343 |
| Disease | FEV/FEC ratio | HSPG2 COL6A3 HTRA1 SLC2A9 DSP MCC NCAM1 MCM7 R3HDM2 INPP4B TFE3 FCGBP MTCL1 SLC14A2 D2HGDH | 3.05e-03 | 1228 | 161 | 15 | EFO_0004713 |
| Disease | myocardial infarction | 3.20e-03 | 350 | 161 | 7 | EFO_0000612 | |
| Disease | cortical thickness | HSPG2 NUP210L NCAM1 SLC12A8 TSC22D2 MLLT10 TENM2 VPS13D CDH20 PTPRF PKHD1 MTCL1 PCDH7 PLCE1 | 3.23e-03 | 1113 | 161 | 14 | EFO_0004840 |
| Disease | vital capacity | HSPG2 COL6A3 HTRA1 SLC2A9 DSP MLLT10 TENM2 GFPT1 NCOR1 PTPRD MAD1L1 MTCL1 ALDH2 SLC14A2 PLCE1 | 3.24e-03 | 1236 | 161 | 15 | EFO_0004312 |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 3.38e-03 | 16 | 161 | 2 | C0751885 | |
| Disease | Spondyloepiphyseal Dysplasia | 3.38e-03 | 16 | 161 | 2 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 3.38e-03 | 16 | 161 | 2 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 3.38e-03 | 16 | 161 | 2 | C4551479 | |
| Disease | response to methotrexate | 3.38e-03 | 16 | 161 | 2 | GO_0031427 | |
| Disease | Polyposis, Adenomatous Intestinal | 3.38e-03 | 16 | 161 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 3.38e-03 | 16 | 161 | 2 | C2713443 | |
| Disease | Schwartz-Jampel Syndrome | 3.38e-03 | 16 | 161 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 3.38e-03 | 16 | 161 | 2 | C0025237 | |
| Disease | gout, hyperuricemia | 3.38e-03 | 16 | 161 | 2 | EFO_0004274, EFO_0009104 | |
| Disease | alcohol consumption measurement | DTD1 GPN1 SGPP2 NCAM1 GRM3 CIT SYT10 TENM2 INPP4B MAD1L1 PKHD1 SMU1 ALDH2 SLC14A2 MYBPC3 | 3.39e-03 | 1242 | 161 | 15 | EFO_0007878 |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 3.81e-03 | 17 | 161 | 2 | C0751883 | |
| Disease | response to radiation, Urinary retention | 3.81e-03 | 17 | 161 | 2 | GO_0009314, HP_0000016 | |
| Disease | Van Buchem disease | 3.81e-03 | 17 | 161 | 2 | C0432272 | |
| Disease | Adenomatous Polyposis Coli | 3.81e-03 | 17 | 161 | 2 | C0032580 | |
| Disease | bacteriemia | 3.81e-03 | 17 | 161 | 2 | EFO_0003033 | |
| Disease | HMG CoA reductase inhibitor use measurement | 3.87e-03 | 189 | 161 | 5 | EFO_0009932 | |
| Disease | Age-related macular degeneration | 4.27e-03 | 18 | 161 | 2 | cv:C0242383 | |
| Disease | sugar consumption measurement | 4.30e-03 | 120 | 161 | 4 | EFO_0010158 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 4.42e-03 | 121 | 161 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | pain | 4.51e-03 | 196 | 161 | 5 | EFO_0003843 | |
| Disease | gout | 4.51e-03 | 196 | 161 | 5 | EFO_0004274 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 4.76e-03 | 19 | 161 | 2 | C0751884 | |
| Disease | Pancreatic carcinoma | 4.76e-03 | 19 | 161 | 2 | C0235974 | |
| Disease | Osteochondrodysplasias | 4.76e-03 | 19 | 161 | 2 | C0029422 | |
| Disease | Dyschondroplasias | 4.76e-03 | 19 | 161 | 2 | C0013366 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 5.25e-03 | 127 | 161 | 4 | EFO_0008595, EFO_0020947 | |
| Disease | Multiple Epiphyseal Dysplasia | 5.27e-03 | 20 | 161 | 2 | C0026760 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TGAVTTVGVAAGLLA | 131 | Q9NWW9 | |
| TVASVVTSTLLAGLG | 506 | P23470 | |
| SAGVGRTGTYIVIDS | 1061 | P23470 | |
| DITGDGTTSNVLIIG | 86 | P40227 | |
| ASSIAGGTGITILII | 136 | Q01362 | |
| TILVTATASSVGAAG | 416 | Q15758 | |
| SASTVALGTGIAGIS | 401 | Q9N2K0 | |
| VGLGLSASTIALSTG | 396 | Q9N2J8 | |
| LATAAGVTSIVSGTL | 116 | Q9BWW8 | |
| SSLSSGAIAGIVIGI | 441 | Q6UY09 | |
| GTLTSDSLVVRGVAG | 536 | Q9HD20 | |
| RTLTGIVIDSGDGVT | 161 | Q9P1U1 | |
| LIAGVIGGSYSSVSI | 141 | Q14832 | |
| TAEISAREGTGLAGV | 171 | Q0P5N6 | |
| GLEISGTFTRQVGSI | 731 | Q10567 | |
| SLSILVVAGSGGHTT | 36 | Q96F25 | |
| TTTTTTTGGILIGDR | 31 | Q9UK58 | |
| GILGRSESVVSGLDS | 426 | O14578 | |
| SGISILTRGDSIGSS | 351 | Q9Y2K5 | |
| TGSSGTLEASVLVTI | 2896 | P98160 | |
| VGLQTEALRGSGVTS | 1646 | Q9Y4B5 | |
| GISRADVIITSGGVS | 561 | Q9NQX3 | |
| SSLGGGHVSERTVIA | 211 | Q8IXS6 | |
| GGRGSQSTVAVVVLA | 531 | Q9UFC0 | |
| TLGTSLLVSAVGLGV | 111 | Q96LR9 | |
| GSVGGESVSVLVLSP | 221 | Q9UKY3 | |
| GSTVSTVGISIILGV | 651 | Q9Y4B6 | |
| TILGSAETSTVGIQG | 601 | Q14667 | |
| RQETVGTLDLGGAST | 191 | O75356 | |
| AIIGAGVSGLASIRS | 6 | P31513 | |
| TSTTGIVIGIHIGVT | 636 | Q8IVU1 | |
| ISQRVEGGSGLDIST | 21 | Q9Y6D9 | |
| NGTIISIILGVGSSR | 216 | Q8IYB1 | |
| LDSGTIRGVSGIGVT | 66 | P09769 | |
| EVVLGRSLGGSATSL | 636 | Q9P244 | |
| SLRTSDGGKVVGTIE | 166 | O15327 | |
| TSRTLGSTDTILIGN | 581 | O15550 | |
| TGSLSGIIGADQVSV | 141 | P14091 | |
| VVRAAGGTLLGVSSQ | 201 | Q96SQ9 | |
| QVGTASGVSDVLRGA | 21 | Q96D98 | |
| AGTSVVVTVGAAGQL | 91 | P29376 | |
| LSITGSVGENGRVLT | 861 | P48058 | |
| VVAETAGSLSGVSIT | 321 | Q15154 | |
| QIGSGSSRLGTAATI | 156 | Q96RV3 | |
| INKREGITAIGGTST | 96 | Q14651 | |
| RATGLSATELGTTVS | 2171 | Q7Z5P9 | |
| VAGVTGTSAEVSGRI | 2336 | Q7Z5P9 | |
| IVTSGQSARVTGATG | 2496 | Q7Z5P9 | |
| VEGLVTTGSSTVGLE | 2841 | Q7Z5P9 | |
| RVTGATEPLAGVTGT | 2961 | Q7Z5P9 | |
| AEVTGTTRLSAGVTG | 3381 | Q7Z5P9 | |
| AGVAGTTTLSAEVTG | 3461 | Q7Z5P9 | |
| AGVTGTTGLSAEVTE | 3481 | Q7Z5P9 | |
| TTRLSAGVTGITGLS | 3526 | Q7Z5P9 | |
| VGVTGITGLSDVVTE | 3571 | Q7Z5P9 | |
| GVTGTTGLSAEATEI | 3811 | Q7Z5P9 | |
| EATEITGLSAGVTGT | 3821 | Q7Z5P9 | |
| TGLSAGVTETIRLSA | 3836 | Q7Z5P9 | |
| GVTETIRLSAGVTGT | 3841 | Q7Z5P9 | |
| GVTGTIRSSAGVTGI | 3851 | Q7Z5P9 | |
| IRSSAGVTGITGLSA | 3856 | Q7Z5P9 | |
| VTGTTGLSVGVTGIA | 3951 | Q7Z5P9 | |
| VTGKTGLSAGVTETI | 4011 | Q7Z5P9 | |
| VTRTTGLSAGVTGIT | 4081 | Q7Z5P9 | |
| VTGITGLSAIVTETT | 4091 | Q7Z5P9 | |
| LSAGVTGTVGSSAVV | 4166 | Q7Z5P9 | |
| LSAVVTGITGLSAEV | 4266 | Q7Z5P9 | |
| LSAEVTGTTGLSAGV | 4276 | Q7Z5P9 | |
| LSAGVTGITGLSAEV | 4286 | Q7Z5P9 | |
| TGITGLSAEVTRTTG | 4291 | Q7Z5P9 | |
| LSAEVTRTTGLSAGV | 4296 | Q7Z5P9 | |
| LSAGVTGITGLSAIV | 4396 | Q7Z5P9 | |
| TGITGLSAIVTETTG | 4401 | Q7Z5P9 | |
| SAVVTGINGLSAGVT | 4496 | Q7Z5P9 | |
| SAVVTGITGLSAEVT | 4606 | Q7Z5P9 | |
| SAGVTGTAGLSARVT | 4676 | Q7Z5P9 | |
| GTAGLSARVTESTGL | 4681 | Q7Z5P9 | |
| ESTGLSAGVTGTIRS | 4761 | Q7Z5P9 | |
| GTIRSSAVVTGINGL | 4771 | Q7Z5P9 | |
| SAVVTGINGLSAGVT | 4776 | Q7Z5P9 | |
| SAVVTGISGLSAEVT | 4866 | Q7Z5P9 | |
| SAGVTGTTGLSARVT | 4946 | Q7Z5P9 | |
| GTTGLSARVTESTGL | 4951 | Q7Z5P9 | |
| GTIGSSAVVTETTRL | 4971 | Q7Z5P9 | |
| LAEVTGTTGLSAGVT | 5016 | Q7Z5P9 | |
| SAVVTGIKGLSAGVT | 5116 | Q7Z5P9 | |
| SAVVTGISGLSGEVT | 5206 | Q7Z5P9 | |
| GTIRSSAVVTETTGL | 5291 | Q7Z5P9 | |
| GTTGLSARVTESTGL | 5341 | Q7Z5P9 | |
| GTIGSSAVVTETTRL | 5361 | Q7Z5P9 | |
| GTARLSAVVTGISGL | 5521 | Q7Z5P9 | |
| SAVVTGISGLSAEVT | 5526 | Q7Z5P9 | |
| ETTGLSAGVTETIGL | 5601 | Q7Z5P9 | |
| SAGVTETIGLSAGVT | 5606 | Q7Z5P9 | |
| SAGVTEITGLSAGVT | 5626 | Q7Z5P9 | |
| SAGVTETIGLSAGVT | 5806 | Q7Z5P9 | |
| AGVTGTTGLSVEATV | 5936 | Q7Z5P9 | |
| VEATVTTGLSAGVTG | 5946 | Q7Z5P9 | |
| ISEVSNTGITGVGSE | 6221 | Q7Z5P9 | |
| IITGDTGELSGTTII | 6921 | Q7Z5P9 | |
| SLGESGKTRVETITG | 7481 | Q7Z5P9 | |
| VASDLGIVTGSGEVT | 51 | O60245 | |
| SVSSILQVGGTIIGS | 81 | Q01813 | |
| RVTIFGESAGGTSVS | 221 | O00748 | |
| SVILISRISSVGGEA | 6 | P36980 | |
| AAGGIVAVSSSAIVT | 431 | Q9ULH7 | |
| TEAGGSGVLQTRTTI | 656 | Q8N3D4 | |
| AAGGVVTTTASGKRI | 261 | P56270 | |
| VLAVVAGDTVSTGST | 16 | Q86TH1 | |
| LGHVVGTEIIRSSTG | 246 | P34903 | |
| RIIVAAGVTDTGLTS | 511 | Q2TBA0 | |
| IEIGAGTGLVSIVAS | 121 | A6NDL7 | |
| EGGARVVVSLTEGTA | 891 | Q86UT6 | |
| LERDGGSGNSTIIVS | 2356 | Q7Z6Z7 | |
| VTERVVSGAGVTGIS | 951 | Q02413 | |
| SSLRVVGVSAVLGTG | 236 | Q9HCN4 | |
| GVGLTAAVLRDSVSG | 411 | P33993 | |
| SVRTSGRSSGLGTDV | 1281 | O95248 | |
| SAGVGRTGVFITLSI | 1881 | Q13332 | |
| RGSSGVGLTAAVTTD | 371 | P25205 | |
| LSAGTGIGVSSALVS | 476 | Q6PIJ6 | |
| LSTVTAIIDGTGSVG | 461 | P57057 | |
| TVTAIIDGTGSIGAA | 431 | Q8TED4 | |
| ASVTVGGEQISAIGR | 11 | Q8TEA8 | |
| RTLTGTVIDSGDGVT | 161 | P61158 | |
| VLGSEISSIGVSSSV | 346 | P23508 | |
| TSRAVQEAGLGLSTG | 331 | Q5TZA2 | |
| TVTTGIVSTTQRGGK | 291 | Q92743 | |
| GALTVGVTNTVGSSI | 441 | O94808 | |
| GADVVVTTTSGLSLA | 4576 | Q9Y6R7 | |
| LGGLAGTTTVNITLS | 251 | Q9HBT6 | |
| GFGSGLATVHVTTVV | 1351 | P01031 | |
| ITITGSDGSTRVVLV | 2506 | P15924 | |
| VGSEGTLGLITATTL | 246 | Q86WU2 | |
| QVIRSSGIVSLGVGD | 1561 | P12111 | |
| GAVTSSLGISVRSGS | 76 | Q8IUK8 | |
| LGAASAVTGITTSIV | 226 | O95236 | |
| QELQSLTGTVGVTSG | 61 | Q0VDD8 | |
| SGTRDSISLTIVGTQ | 16 | O75342 | |
| SVTVSIFAIGGLVGT | 111 | Q9NRM0 | |
| GGLSGTTTVNITLTD | 246 | P55285 | |
| VVAGSVTVLSGRRGT | 371 | Q9Y6C2 | |
| ISEGTVLAARAGTSG | 731 | Q66K89 | |
| RNAVVVITGATSGLG | 51 | Q6IAN0 | |
| VNIGSLSTGGRVSAV | 406 | Q2VIR3 | |
| AGAVILGGVTRLTES | 81 | Q7KZN9 | |
| SVILISRISSVGGEA | 6 | Q03591 | |
| IGVSLTSSLVASGLG | 391 | P60507 | |
| TSSLVASGLGTGAIV | 396 | P60507 | |
| LVTVLSGIGVGERSS | 86 | A0AV02 | |
| ATIGGLTTIIGTSTS | 276 | Q9UKG4 | |
| VGVTSTASRVGSIIA | 461 | Q9H015 | |
| GGLSGTTTVNITLTD | 246 | Q9ULB4 | |
| TVTTLSDGSVVLNGG | 466 | Q92630 | |
| GLGVAVVSSLVNGST | 31 | Q7RTP0 | |
| TSRTITLTNVGGLGT | 636 | Q9C0B2 | |
| IGSEGTLGIITTVSI | 256 | Q8N465 | |
| TQVGGVGLTLTAATR | 536 | Q2NKX8 | |
| TAGGISRVSSIRSVG | 21 | O76013 | |
| AGSIAGTAVLEVTSI | 1346 | Q5VU65 | |
| TDIVTGVGVARSPGT | 1521 | Q5VU65 | |
| FTLGGTNTGIATTIT | 76 | Q9BVL2 | |
| AGVGRTGVFITLSIV | 1841 | P10586 | |
| AGVGRTGVFITLSIV | 1846 | P23468 | |
| GVITVSGLAGLVSAR | 116 | Q6UXV4 | |
| AISAGTGASGIVEVL | 571 | Q96AX9 | |
| RSVLTTGIGSTSAGL | 371 | Q9NXL9 | |
| VVQGGLDTTRSALTG | 106 | Q96Q06 | |
| TGTKDTVTTGLVGAV | 581 | Q96Q06 | |
| KLRGSGVAVETGTVS | 176 | Q9UI12 | |
| DVTGDGTTSNVLIIG | 86 | Q92526 | |
| TAVCTGGVTESRGIV | 11 | Q14DG7 | |
| GAGGSSVTLVAEVNV | 991 | O15061 | |
| GVVSARSVSGALAST | 106 | O75157 | |
| ERGALTVGITNTVGS | 456 | Q06210 | |
| ASGRTTITAIVQTGG | 56 | A1L4L8 | |
| SIVTNGTGIESTSLG | 1306 | Q9P212 | |
| GNSITGIISSVLGHI | 831 | Q5UIP0 | |
| VVRGTAGAIQEGSIT | 1131 | O75376 | |
| TDRSVAGGGTVSVSV | 331 | Q9NTX7 | |
| EAGDGTTSVVIIAGS | 101 | P50991 | |
| SADGDLVTLGTTIGR | 2626 | Q9NT68 | |
| THGTIIGITSGIVLV | 346 | Q8NC67 | |
| GTEEGSGLVLVTTQR | 766 | P08F94 | |
| LTIEGTGLRGQNTTS | 1591 | P08F94 | |
| GSRVVAQGTGSTTDL | 956 | Q5JTZ9 | |
| DTTTILAAGAGVTIG | 276 | Q8IWX5 | |
| TVSVTGAGTDGLLAL | 1786 | Q9Y566 | |
| VRTGSTGLKATNVEG | 566 | P0C7V6 | |
| SRVTGGIFSVTKGAV | 36 | Q8WUH6 | |
| VDTQVGTVTSLTAGG | 391 | P13798 | |
| TSTIPAVSAVGGIIG | 886 | P55197 | |
| TGSTEIGRVIQVAAG | 261 | P05091 | |
| GRIASLTSGLAVGQT | 276 | Q13733 | |
| TSGLSTGAIVGILIV | 716 | P13591 | |
| ATGEVSGRTLIDIGS | 66 | P11086 | |
| RTSTTNGGILTVSID | 221 | Q96QD9 | |
| IGGDLTAAVTKTVGT | 196 | Q7Z739 | |
| AGTVTTGVGGVAVTS | 906 | Q5TCY1 | |
| GILTIDVTSVSSSLG | 536 | Q2QGD7 | |
| GDSSRTSLVSTIAGI | 121 | Q14119 | |
| TSVEQGSGLLSTLVG | 2676 | Q8IZQ1 | |
| AISVVGVSAGGHTLS | 151 | P19532 | |
| GSTAGTDITVNSVIL | 391 | Q2TAY7 | |
| SDVISGVSTGLVATL | 86 | O43511 | |
| GADRSGSTAVGVLIS | 121 | P35813 | |
| GTGSGSVSHAIIRTI | 111 | Q96FX7 | |
| GISAITISDVSGTIV | 3026 | Q6ZS81 | |
| SVTLRVTGESHIGGV | 31 | Q86UX7 | |
| GGSSTDISVSLLAVV | 46 | Q6XYQ8 | |
| QTSSVLVSGLRGLGV | 71 | P22314 | |
| RVVAGEGSGSVSLAL | 151 | P41273 | |
| GIGESVLVSSGTHTV | 311 | Q9C0K7 | |
| VLETGGEAGITRSVV | 51 | Q7Z2W4 | |
| EGIAGVATSTGVVTS | 1381 | Q9H4A3 | |
| VATSTGVVTSGGLPI | 1386 | Q9H4A3 | |
| TIAGVLSGFLIGSVS | 296 | Q6UX68 | |
| GSTAVGIRGTNIVVL | 31 | Q8TAA3 | |
| GGLGTVVSTLTALAL | 156 | Q15849 | |
| SAGVGRTGTLIALDV | 1021 | Q9HD43 | |
| LTTGSVVQGTLGVST | 876 | Q9ULM3 | |
| VVSSVALTGVLSGNG | 206 | Q9BYJ9 | |
| IIGFGISGRHSITVT | 26 | Q7Z7D3 | |
| GIIGGLTSVITSTVE | 4156 | Q5THJ4 | |
| VNIGSLSTGGRVSAV | 406 | P41091 | |
| TGESAGALTVGLVRQ | 31 | Q8NHV5 | |
| VPLEAVTGLSVTSGG | 911 | B0I1T2 | |
| VTGLSVTSGGDQLVV | 916 | B0I1T2 | |
| VTVGGSITFSARVAG | 166 | Q14896 | |
| GTLAGTVTVTSRFTL | 211 | Q92692 |